These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26857244)

  • 1. A multicenter, epidemiological study of the treatment patterns, comorbidities and hypoglycemia events of patients with type 2 diabetes and moderate or severe chronic kidney disease - the 'LEARN' study.
    Rombopoulos G; Panitti E; Varounis C; Katsinas C; Stefanidis I; Goumenos D
    Curr Med Res Opin; 2016 May; 32(5):939-47. PubMed ID: 26857244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemia in People with Type 2 Diabetes and CKD.
    Ahmad I; Zelnick LR; Batacchi Z; Robinson N; Dighe A; Manski-Nankervis JE; Furler J; O'Neal DN; Little R; Trence D; Hirsch IB; Bansal N; de Boer IH
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):844-853. PubMed ID: 30996047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4.
    Betônico CC; Titan SMO; Lira A; Pelaes TS; Correa-Giannella MLC; Nery M; Queiroz M
    Clin Ther; 2019 Oct; 41(10):2008-2020.e3. PubMed ID: 31383366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.
    Penfornis A; Blicklé JF; Fiquet B; Quéré S; Dejager S
    Vasc Health Risk Manag; 2014; 10():341-52. PubMed ID: 24966684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies.
    Liatis S; Iraklianou S; Kazakos K; Mastorakos G; Milios K; Mouslech Z; Noutsou M; Pagkalos E; Sampanis C;
    BMC Endocr Disord; 2019 Apr; 19(1):39. PubMed ID: 31023374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.
    Tuttle KR; Lakshmanan MC; Rayner B; Busch RS; Zimmermann AG; Woodward DB; Botros FT
    Lancet Diabetes Endocrinol; 2018 Aug; 6(8):605-617. PubMed ID: 29910024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
    Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
    J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational study.
    Zhang B; Zhao J; Yang W;
    Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27667797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
    Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
    Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia.
    Thorpe CT; Gellad WF; Good CB; Zhang S; Zhao X; Mor M; Fine MJ
    Diabetes Care; 2015 Apr; 38(4):588-95. PubMed ID: 25592195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications.
    Huri HZ; Lim LP; Lim SK
    Drug Des Devel Ther; 2015; 9():4355-71. PubMed ID: 26300627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [RESOLUTE Study in the Czech Republic: insulin glargine improves the compensation of type 2 diabetes in patients with unsatisfactory results of therapy with a combination of insulin detemir and oral antidiabetics. Results of the nonintervention RESOLUTE Project in the Czech Republic].
    Kvapil M
    Vnitr Lek; 2013 Sep; 59(9):800-6. PubMed ID: 24073952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of hypoglycemia and its impact on the quality of life (QoL) of type 2 diabetes mellitus patients (The HYPO Study).
    Rombopoulos G; Hatzikou M; Latsou D; Yfantopoulos J
    Hormones (Athens); 2013; 12(4):550-8. PubMed ID: 24457403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study.
    Gonzalez C; Monti C; Pinzon A; Monsanto H; Ejzykowicz F;
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):592-602. PubMed ID: 30076124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of type 2 diabetes mellitus in patients with chronic kidney disease. Grupo de Trabajo para el Documento de Consenso sobre el tratamiento de la diabetes tipo 2 en el paciente con enfermedad renal crónica].
    Gómez-Huelgas R; Martínez-Castelao A; Artola S; Górriz JL; Menéndez E;
    Med Clin (Barc); 2014 Jan; 142(2):85.e1-10. PubMed ID: 24268912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of diabetes treatment with long-term glycemic patterns in patients with type 2 diabetes mellitus: A prospective cohort study.
    Luo M; Tan CS; Lim WY; Chia KS; Tang WE; Tai ES; Venkataraman K
    Diabetes Metab Res Rev; 2019 May; 35(4):e3122. PubMed ID: 30600922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Titration of basal insulin or immediate addition of rapid acting insulin in patients not at target using basal insulin supported oral antidiabetic treatment - A prospective observational study in 2202 patients.
    Siegmund T; Pfohl M; Forst T; Pscherer S; Bramlage P; Foersch J; Borck A; Seufert J
    Diabetes Metab Syndr; 2017; 11(1):51-57. PubMed ID: 27578616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment.
    Mata-Cases M; Franch-Nadal J; Real J; Gratacòs M; López-Simarro F; Khunti K; Mauricio D
    Diabetes Obes Metab; 2018 Jan; 20(1):103-112. PubMed ID: 28656746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.